241 related articles for article (PubMed ID: 23777098)
21. Diagnostic and clinical classification of autoimmune myasthenia gravis.
Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
[TBL] [Abstract][Full Text] [Related]
22. Serological and experimental studies in different forms of myasthenia gravis.
Vincent A; Huda S; Cao M; Cetin H; Koneczny I; Rodriguez Cruz PM; Jacobson L; Viegas S; Jacob S; Woodhall M; Nagaishi A; Maniaol A; Damato V; Leite MI; Cossins J; Webster R; Palace J; Beeson D
Ann N Y Acad Sci; 2018 Feb; 1413(1):143-153. PubMed ID: 29377162
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.
Lazaridis K; Tzartos SJ
Front Immunol; 2020; 11():212. PubMed ID: 32117321
[TBL] [Abstract][Full Text] [Related]
25. [Anti-MuSK antibodies in myasthenia gravis block binding of collagen Q to MuSK].
Ohno K
Rinsho Shinkeigaku; 2012; 52(11):1306-8. PubMed ID: 23196600
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to agrin in myasthenia gravis patients.
Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.
Rivner MH; Quarles BM; Pan JX; Yu Z; Howard JF; Corse A; Dimachkie MM; Jackson C; Vu T; Small G; Lisak RP; Belsh J; Lee I; Nowak RJ; Baute V; Scelsa S; Fernandes JA; Simmons Z; Swenson A; Barohn R; Sanka RB; Gooch C; Ubogu E; Caress J; Pasnoor M; Xu H; Mei L
Muscle Nerve; 2020 Sep; 62(3):333-343. PubMed ID: 32483837
[TBL] [Abstract][Full Text] [Related]
28. Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis.
Yan M; Xing GL; Xiong WC; Mei L
Ann N Y Acad Sci; 2018 Feb; 1413(1):126-135. PubMed ID: 29377176
[TBL] [Abstract][Full Text] [Related]
29. MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.
Huijbers MG; Zhang W; Klooster R; Niks EH; Friese MB; Straasheijm KR; Thijssen PE; Vrolijk H; Plomp JJ; Vogels P; Losen M; Van der Maarel SM; Burden SJ; Verschuuren JJ
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20783-8. PubMed ID: 24297891
[TBL] [Abstract][Full Text] [Related]
30. Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.
Li M; Han J; Zhang Y; Lv J; Zhang J; Zhao X; Ren L; Fang H; Yang J; Zhang Y; Cui X; Zhang Q; Li Q; Du Y; Gao F
Eur J Neurol; 2019 Oct; 26(10):1296-e84. PubMed ID: 31050101
[TBL] [Abstract][Full Text] [Related]
31. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis.
Romi F; Suzuki S; Suzuki N; Petzold A; Plant GT; Gilhus NE
J Neurol; 2012 Jul; 259(7):1312-6. PubMed ID: 22167224
[TBL] [Abstract][Full Text] [Related]
32. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
Koneczny I; Herbst R
Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
[TBL] [Abstract][Full Text] [Related]
33. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
Huda S; Woodhall MR; Vincent A; Heckmann JM
Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
[TBL] [Abstract][Full Text] [Related]
34. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
35. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
36. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
[TBL] [Abstract][Full Text] [Related]
37. Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis.
Mori S; Yamada S; Kubo S; Chen J; Matsuda S; Shudou M; Maruyama N; Shigemoto K
J Neuroimmunol; 2012 Mar; 244(1-2):1-7. PubMed ID: 22222307
[TBL] [Abstract][Full Text] [Related]
38. Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies.
Yamashita R; Shimizu M; Baba K; Beck G; Kinoshita M; Okuno T; Higuchi O; Mochizuki H
Intern Med; 2021 Jan; 60(1):137-140. PubMed ID: 32830177
[TBL] [Abstract][Full Text] [Related]
39. MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.
Tsonis AI; Zisimopoulou P; Lazaridis K; Tzartos J; Matsigkou E; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Tzartos SJ
J Neuroimmunol; 2015 Jul; 284():10-7. PubMed ID: 26025053
[TBL] [Abstract][Full Text] [Related]
40. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
